Illumina | ILMN - Market Capitalization


Illumina reported $19.15B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 41.49B 8.93B Sep/2025
Bio Techne USD 10.78B 1.62B Feb/2026
Bio-Rad Laboratories USD 6.7B 908M Feb/2026
Boston Scientific USD 110.32B 31.04B Feb/2026
Bruker USD 5.69B 1.47B Feb/2026
Charles River Laboratories USD 8.08B 1.94B Feb/2026
Danaher USD 161.7B 29.34B Dec/2025
Dentsply International USD 2.53B 633M Sep/2025
Edwards Lifesciences USD 44.75B 4.72B Feb/2026
Exact Sciences USD 10.36B 334M Sep/2025
Hologic USD 16.62B 1.67B Dec/2025
Illumina USD 21.21B 588M Feb/2026
Intuitive Surgical USD 200.77B 40.45B Dec/2025
IQVIA Holdings USD 32.84B 5.54B Feb/2026
Laboratory Of America USD 23.77B 2.98B Feb/2026
Mettler Toledo International USD 29.7B 1.22B Feb/2026
Myriad Genetics USD 494M 316M Jun/2025
OraSure Technologies USD 435M 68M Sep/2023
Pacific Biosciences Of California USD 2.62B 532M Dec/2023
Quest Diagnostics USD 23.09B 3.79B Feb/2026
Quidel USD 1.92B 65M Feb/2026
Repligen USD 7.51B 1.71B Feb/2026
Revvity USD 12.58B 1.61B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Standard Biotools USD 521M 24M Feb/2026
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Waters USD 19.14B 3.47B Feb/2026